Correlation Between YuantaP Shares and Synmosa Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both YuantaP Shares and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining YuantaP Shares and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between YuantaP shares Taiwan Top and Synmosa Biopharma, you can compare the effects of market volatilities on YuantaP Shares and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in YuantaP Shares with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of YuantaP Shares and Synmosa Biopharma.

Diversification Opportunities for YuantaP Shares and Synmosa Biopharma

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between YuantaP and Synmosa is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding YuantaP shares Taiwan Top and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and YuantaP Shares is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on YuantaP shares Taiwan Top are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of YuantaP Shares i.e., YuantaP Shares and Synmosa Biopharma go up and down completely randomly.

Pair Corralation between YuantaP Shares and Synmosa Biopharma

Assuming the 90 days trading horizon YuantaP Shares is expected to generate 18.75 times less return on investment than Synmosa Biopharma. But when comparing it to its historical volatility, YuantaP shares Taiwan Top is 38.59 times less risky than Synmosa Biopharma. It trades about 0.1 of its potential returns per unit of risk. Synmosa Biopharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  3,520  in Synmosa Biopharma on September 12, 2024 and sell it today you would lose (150.00) from holding Synmosa Biopharma or give up 4.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.27%
ValuesDaily Returns

YuantaP shares Taiwan Top  vs.  Synmosa Biopharma

 Performance 
       Timeline  
YuantaP shares Taiwan 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in YuantaP shares Taiwan Top are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, YuantaP Shares may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Synmosa Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Synmosa Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

YuantaP Shares and Synmosa Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with YuantaP Shares and Synmosa Biopharma

The main advantage of trading using opposite YuantaP Shares and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if YuantaP Shares position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.
The idea behind YuantaP shares Taiwan Top and Synmosa Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings